IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11166929 B1

PDFFull Text
Date of Patent:
Nov. 09, 2021

Filed:

Oct. 19, 2018

Fatty-acid based particles

Applicant:

Atrium Medical Corporation, Merrimack, NH (US);

Inventors:

Thomas M. Swanick, Hillsborough, NH (US);

Joseph Ferraro, Londonderry, NH (US);

Lisa Rogers, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Assignee:

ATRIUM MEDICAL CORPORATION, Merrimack, NH (US);

Attorney:

Wesley Scott Ashton

Primary Examiner:

Robert A Wax

Assistant Examiner:

Caralynne E Helm

Int. Cl.
CPC ...
A61K 31/20 (2006.01); A61K 9/14 (2006.01); A61K 9/70 (2006.01); A61K 31/00 (2006.01); A61K 31/4353 (2006.01); A61K 31/496 (2006.01); A61K 31/7028 (2006.01); A61K 38/13 (2006.01); A61K 9/16 (2006.01); A61K 31/436 (2006.01); A61K 35/60 (2006.01); A61L 27/54 (2006.01); A61L 31/16 (2006.01); A61K 9/10 (2006.01); A61K 31/4545 (2006.01); A61K 31/445 (2006.01); A61K 31/7036 (2006.01); A61L 27/28 (2006.01); A61L 31/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/20 (2013.01); A61K 9/10 (2013.01); A61K 9/145 (2013.01); A61K 9/16 (2013.01); A61K 9/7007 (2013.01); A61K 31/00 (2013.01); A61K 31/436 (2013.01); A61K 31/4353 (2013.01); A61K 31/445 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/7028 (2013.01); A61K 31/7036 (2013.01); A61K 35/60 (2013.01); A61K 38/13 (2013.01); A61L 27/28 (2013.01); A61L 27/54 (2013.01); A61L 31/08 (2013.01); A61L 31/16 (2013.01); A61L 2300/606 (2013.01);
Abstract

The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.

Find Patent Forward Citations

Loading…